Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-07-29 5:23 pm Purchase |
2025-07-22 | 13G | MEI Pharma, Inc. MEIP |
Citadel Advisors LLC | 3,245,888 9.990% |
3,245,888 (New Position) |
Filing History |
| 2025-07-25 7:24 pm Purchase |
2025-07-18 | 13G | NioCorp Developments Ltd. NB |
Citadel Advisors LLC | 3,903,395 5.400% |
3,903,395 (New Position) |
Filing History |
| 2025-07-16 6:02 pm Purchase |
2025-07-09 | 13G | Allogene Therapeutics, Inc. ALLO |
Citadel Advisors LLC | 13,346,151 6.100% |
13,346,151 (New Position) |
Filing History |
| 2025-07-10 5:38 pm Purchase |
2025-07-02 | 13G | Alignment Healthcare, Inc. ALHC |
Citadel Advisors LLC | 10,508,059 5.300% |
10,508,059 (New Position) |
Filing History |
| 2025-07-07 5:50 pm Purchase |
2025-06-27 | 13G | Nano Labs Ltd NA |
Citadel Advisors LLC | 2,085,799 9.500% |
2,085,799 (New Position) |
Filing History |
| 2025-06-20 5:22 pm Purchase |
2025-06-12 | 13G | Cabaletta Bio, Inc. CABA |
Citadel Advisors LLC | 4,818,560 5.200% |
4,721,158 (+4847.09%) |
Filing History |
| 2025-05-19 4:38 pm Purchase |
2025-05-12 | 13G | ADT Inc. ADT |
Citadel Advisors LLC | 43,895,377 5.600% |
43,895,377 (New Position) |
Filing History |
| 2025-05-15 5:38 pm Sale |
2025-03-31 | 13G | Sphere Entertainment Co. SPHR |
Citadel Advisors LLC | 1,115,276 3.900% |
-391,681 (-25.99%) |
Filing History |
| 2025-05-15 5:33 pm Sale |
2025-03-31 | 13G | FrontView REIT, Inc. FVR |
Citadel Advisors LLC | 408,540 2.400% |
-441,483 (-51.94%) |
Filing History |
| 2025-05-15 5:29 pm Sale |
2025-03-31 | 13G | Ventyx Biosciences, Inc. VTYX |
Citadel Advisors LLC | 1,409,601 2.000% |
-2,869,952 (-67.06%) |
Filing History |
| 2025-05-15 5:28 pm Sale |
2025-03-31 | 13G | VYNE Therapeutics Inc. VYNE |
Citadel Advisors LLC | 1,100,329 7.200% |
-80,815 (-6.84%) |
Filing History |
| 2025-05-15 5:27 pm Sale |
2025-03-31 | 13G | Chain Bridge Bancorp, Inc. CBNA |
Citadel Advisors LLC | 11,912 0.400% |
-82,970 (-87.45%) |
Filing History |
| 2025-05-15 5:27 pm Purchase |
2025-03-31 | 13G | UWM Holdings Corporation UWMC |
Citadel Advisors LLC | 13,245,064 6.600% |
4,249,968 (+47.25%) |
Filing History |
| 2025-05-15 5:24 pm Purchase |
2025-03-31 | 13G | Acrivon Therapeutics, Inc. Common Stock ACRV |
Citadel Advisors LLC | 1,895,618 6.000% |
245,954 (+14.91%) |
Filing History |
| 2025-05-06 5:22 pm Purchase |
2025-04-29 | 13G | Spirit Aviation Holdings, Inc. FLYY |
Citadel Advisors LLC | 1,624,877 9.900% |
1,624,877 (New Position) |
Filing History |
| 2025-04-14 6:57 pm Purchase |
2025-04-07 | 13G | DBV Technologies S.A. DBVT |
Citadel Advisors LLC | 9,194,107 6.400% |
9,194,107 (New Position) |
Filing History |
| 2025-02-24 5:55 pm Purchase |
2025-02-14 | 13G | Aardvark Therapeutics, Inc. Common Stock AARD |
Citadel Advisors LLC | 1,192,971 5.600% |
1,192,971 (New Position) |
Filing History |
| 2025-02-19 4:50 pm Purchase |
2025-02-11 | 13G | Sun Country Airlines Holdings, Inc. SNCY |
Citadel Advisors LLC | 3,196,914 6.100% |
3,196,914 (New Position) |
Filing History |
| 2025-02-14 6:32 pm Sale |
2024-12-31 | 13G | COMPASS Pathways plc CMPS |
Citadel Advisors LLC | 1,166,576 1.700% |
-4,268,100 (-78.53%) |
Filing History |
| 2025-02-14 6:25 pm Purchase |
2024-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN |
Citadel Advisors LLC | 3,465,307 4.100% |
54,543 (+1.60%) |
Filing History |